First, leptin increases phosphorylation of HER-2/neu, which results in increased proliferation of SK-BR-3 breast cancer cells; second, leptin inhibits ERK1/2 phosphorylation, which is predominant at high leptin concentrations, thereby reducing the effect of increased HER-2/neu signaling. Here, LEP is linked to breast carcinoma.